Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor

Int J Mol Sci. 2010 May 26;11(6):2291-305. doi: 10.3390/ijms11062291.

Abstract

Fibroblast growth factor receptors (FGFRs) interact with their cognate ligands, FGFs, and with a number of cell adhesion molecules (CAMs), such as the neural cell adhesion molecule (NCAM), mediating a wide range of events during the development and maintenance of the nervous system. Determination of protein structure, in silico modeling and biological studies have recently resulted in the identification of FGFR binding peptides derived from various FGFs and NCAM mimicking the effects of these molecules with regard to their neuritogenic and neuroprotective properties. This review focuses on recently developed functional peptide agonists of FGFR with possible therapeutic potential.

Keywords: FGF; FGFR; FGFR agonist; NCAM; neuroprotective effect.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Fibroblast Growth Factors / chemistry
  • Fibroblast Growth Factors / metabolism
  • Humans
  • Ligands
  • Neural Cell Adhesion Molecules / chemistry
  • Neural Cell Adhesion Molecules / metabolism
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / pharmacology*
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology*
  • Protein Binding
  • Receptors, Fibroblast Growth Factor / agonists*
  • Receptors, Fibroblast Growth Factor / chemistry
  • Receptors, Fibroblast Growth Factor / metabolism

Substances

  • Ligands
  • Neural Cell Adhesion Molecules
  • Neuroprotective Agents
  • Peptide Fragments
  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors